Insider · CIK 0001918845
Mittie Doyle
Files at: AVTX, CGEM. On EDGAR ↗
Reported trades — common stock
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 28, 2026 SForm 4 → | Sep 1, 4:38 pm EDT | Avalo Therapeutics, Inc.AVTX | 679 | $20.00 | $13,580 | 51,776 | −1.29% | 10b5-1 |
| Aug 28, 2026 MForm 4 → | Sep 1, 4:38 pm EDT | Avalo Therapeutics, Inc.AVTX | 679 | $8.04 | $5,459 | 52,455 | — | 10b5-1 |
| Aug 17, 2026 SForm 4 → | Aug 19, 4:10 pm EDT | Avalo Therapeutics, Inc.AVTX | 1,000 | $20.00 | $20,000 | 51,776 | −1.89% | 10b5-1 |
| Aug 17, 2026 MForm 4 → | Aug 19, 4:10 pm EDT | Avalo Therapeutics, Inc.AVTX | 1,000 | $12.65 | $12,650 | 52,776 | — | 10b5-1 |
| Aug 10, 2026 SForm 4 → | Aug 12, 4:10 pm EDT | Avalo Therapeutics, Inc.AVTX | 679 | $20.00 | $13,580 | 51,776 | −1.29% | 10b5-1 |
| Aug 10, 2026 MForm 4 → | Aug 12, 4:10 pm EDT | Avalo Therapeutics, Inc.AVTX | 679 | $8.04 | $5,459 | 52,455 | — | 10b5-1 |
| Jul 27, 2026 SForm 4 → | Jul 29, 4:05 pm EDT | Avalo Therapeutics, Inc.AVTX | 1,000 | $20.00 | $20,000 | 51,776 | −1.89% | 10b5-1 |
| Jul 27, 2026 MForm 4 → | Jul 29, 4:05 pm EDT | Avalo Therapeutics, Inc.AVTX | 1,000 | $12.65 | $12,650 | 52,776 | — | 10b5-1 |
| Jun 30, 2026 SForm 4 → | Jul 2, 4:05 pm EDT | Avalo Therapeutics, Inc.AVTX | 4,654 | $20.00 | $93,080 | 51,776 | −8.25% | 10b5-1 |
| Jun 30, 2026 MForm 4 → | Jul 2, 4:05 pm EDT | Avalo Therapeutics, Inc.AVTX | 4,654 | $10.89 | $50,672 | 56,430 | — | 10b5-1 |
Reported trades — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 28, 2026 MForm 4 → | Sep 1, 4:38 pm EDT | Avalo Therapeutics, Inc.AVTX | 679 | — | — | 113,734 | — | 10b5-1 |
| Aug 17, 2026 MForm 4 → | Aug 19, 4:10 pm EDT | Avalo Therapeutics, Inc.AVTX | 1,000 | — | — | 123,750 | — | 10b5-1 |
| Aug 10, 2026 MForm 4 → | Aug 12, 4:10 pm EDT | Avalo Therapeutics, Inc.AVTX | 679 | — | — | 114,413 | — | 10b5-1 |
| Jul 27, 2026 MForm 4 → | Jul 29, 4:05 pm EDT | Avalo Therapeutics, Inc.AVTX | 1,000 | — | — | 124,750 | — | 10b5-1 |
| Jun 30, 2026 MForm 4 → | Jul 2, 4:05 pm EDT | Avalo Therapeutics, Inc.AVTX | 4,654 | — | — | 115,092 | — | 10b5-1 |